دورية أكاديمية
CCL13 and human diseases.
| العنوان: | CCL13 and human diseases. |
|---|---|
| المؤلفون: | Li L; Department of Gastroenterology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.; Shaanxi Province Key Laboratory of Gastrointestinal Motility Disorders, Laboratory of Digestive Diseases of the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Dai F; Department of Gastroenterology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.; Shaanxi Province Key Laboratory of Gastrointestinal Motility Disorders, Laboratory of Digestive Diseases of the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Wang L; Department of Gastroenterology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.; Shaanxi Province Key Laboratory of Gastrointestinal Motility Disorders, Laboratory of Digestive Diseases of the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Sun Y; Department of Gastroenterology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.; Shaanxi Province Key Laboratory of Gastrointestinal Motility Disorders, Laboratory of Digestive Diseases of the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Mei L; Department of Gastroenterology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.; Shaanxi Province Key Laboratory of Gastrointestinal Motility Disorders, Laboratory of Digestive Diseases of the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Ran Y; Department of Gastroenterology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.; Shaanxi Province Key Laboratory of Gastrointestinal Motility Disorders, Laboratory of Digestive Diseases of the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Ye F; Department of Gastroenterology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.; Shaanxi Province Key Laboratory of Gastrointestinal Motility Disorders, Laboratory of Digestive Diseases of the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. |
| المصدر: | Frontiers in immunology [Front Immunol] 2023 Apr 19; Vol. 14, pp. 1176639. Date of Electronic Publication: 2023 Apr 19 (Print Publication: 2023). |
| نوع المنشور: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: [Lausanne : Frontiers Research Foundation] |
| مواضيع طبية MeSH: | Chemokines, CC* , Monocyte Chemoattractant Proteins*, Humans |
| مستخلص: | CCL13/MCP-4 belongs to the CC chemokine family, which induces chemotaxis in many immune cells. Despite extensive research into its function in numerous disorders, a thorough analysis of CCL13 is not yet accessible. The role of CCL13 in human disorders and existing CCL13-focused therapies are outlined in this study. The function of CCL13 in rheumatic diseases, skin conditions, and cancer is comparatively well-established, and some studies also suggest that it may be involved in ocular disorders, orthopedic conditions, nasal polyps, and obesity. We also give an overview of research that found very little evidence of CCL13 in HIV, nephritis, and multiple sclerosis. Even though CCL13-mediated inflammation is frequently linked to disease pathogenesis, it's fascinating to note that in some conditions, like primary biliary cholangitis (PBC) and suicide, it might even act as a preventative measure. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2023 Li, Dai, Wang, Sun, Mei, Ran and Ye.) |
| References: | Ocul Immunol Inflamm. 2017 Aug;25(4):569-576. (PMID: 27428361) Mol Oncol. 2019 Feb;13(2):376-391. (PMID: 30451357) Lab Invest. 2012 Apr;92(4):615-24. (PMID: 22157716) Annu Rev Pathol. 2017 Jan 24;12:331-357. (PMID: 27959637) Br J Dermatol. 2011 Jul;165(1):216-8. (PMID: 21428976) J Pharmacol Exp Ther. 2006 Apr;317(1):244-50. (PMID: 16339911) Nature. 2006 Dec 14;444(7121):860-7. (PMID: 17167474) Rheumatology (Oxford). 2006 Apr;45(4):421-4. (PMID: 16303818) Sci Transl Med. 2014 Dec 3;6(265):265sr6. (PMID: 25473038) Cytokine. 2017 Feb;90:185-192. (PMID: 27940218) Cardiovasc Res. 2010 May 1;86(2):265-73. (PMID: 20139115) Lancet. 2013 Nov 9;382(9904):1587-99. (PMID: 23810223) Psychoneuroendocrinology. 2013 Jun;38(6):853-62. (PMID: 23062672) Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2840-9. (PMID: 25249326) Int Immunopharmacol. 2014 May;20(1):1-11. (PMID: 24560857) Acta Ophthalmol. 2019 Jun;97(4):e580-e588. (PMID: 30561135) Biomed Res Int. 2020 Mar 19;2020:1497175. (PMID: 32280674) Acta Otolaryngol. 2007 Dec;127(12):1304-9. (PMID: 17851891) Sci Rep. 2016 Jun 08;6:27376. (PMID: 27271011) Lancet. 2019 Apr 27;393(10182):1745-1759. (PMID: 31034380) Transl Psychiatry. 2017 Feb 7;7(2):e1025. (PMID: 28170001) Lancet. 2022 May 28;399(10340):2047-2064. (PMID: 35598608) Transl Psychiatry. 2020 Jan 23;10(1):31. (PMID: 32066664) Exp Dermatol. 2021 May;30(5):723-732. (PMID: 33523560) Front Cell Neurosci. 2015 Sep 10;9:357. (PMID: 26441528) J BUON. 2021 Sep-Oct;26(5):2040-2052. (PMID: 34761615) Osteoarthritis Cartilage. 2020 May;28(5):603-612. (PMID: 31730805) Cardiovasc Res. 2016 Feb 1;109(2):228-39. (PMID: 26645979) Clin Exp Immunol. 2008 May;152(2):354-63. (PMID: 18336592) Clin Exp Allergy. 2011 Nov;41(11):1568-78. (PMID: 21801248) Cancer Lett. 2022 Oct 17;551:215972. (PMID: 36265653) J Immunol. 2009 May 15;182(10):6237-46. (PMID: 19414777) J Surg Oncol. 2016 Sep;114(4):483-9. (PMID: 27349356) Mol Vis. 2019 Nov 15;25:756-765. (PMID: 31814701) Int J Cancer. 2002 Jun 10;99(5):665-72. (PMID: 12115499) N Engl J Med. 2011 Dec 8;365(23):2205-19. (PMID: 22150039) Curr Top Behav Neurosci. 2018;40:45-78. (PMID: 29626340) Anticancer Res. 2016 Aug;36(8):4013-8. (PMID: 27466507) Cytokine Growth Factor Rev. 1999 Mar;10(1):61-86. (PMID: 10379912) JAMA Intern Med. 2015 Apr;175(4):588-96. (PMID: 25706928) J Am Acad Dermatol. 2021 Feb;84(2):370-380. (PMID: 32376430) Int J Mol Med. 2007 Jun;19(6):941-6. (PMID: 17487427) Science. 2013 Sep 20;341(6152):1387-90. (PMID: 24030490) J Hepatol. 2013 Jun;58(6):1125-32. (PMID: 23402745) Int Forum Allergy Rhinol. 2019 Jul;9(7):776-786. (PMID: 30775848) J Allergy Clin Immunol. 2019 Jul;144(1):144-156. (PMID: 30685456) Cytokine. 2020 Dec;136:155291. (PMID: 32956949) Stem Cells Dev. 2015 May 15;24(10):1223-35. (PMID: 25579056) Gastric Cancer. 2017 Jan;20(1):92-103. (PMID: 26694715) J Gastroenterol Hepatol. 2019 Apr;34(4):764-775. (PMID: 30695096) Int Wound J. 2019 Dec;16(6):1281-1288. (PMID: 31475447) APMIS. 2017 Feb;125(2):148-156. (PMID: 27859623) J Allergy Clin Immunol. 2001 Apr;107(4):664-70. (PMID: 11295656) PLoS One. 2009;4(5):e5263. (PMID: 19421322) Allergy. 2022 Jun;77(6):1772-1785. (PMID: 34839541) Arthritis Rheum. 2009 Jul;60(7):1932-43. (PMID: 19565514) J Allergy Clin Immunol. 2020 Nov;146(5):1056-1069. (PMID: 32344053) Int J Mol Sci. 2017 Aug 22;18(8):. (PMID: 28829369) Lancet. 2016 Oct 22;388(10055):2023-2038. (PMID: 27156434) J Invest Dermatol. 2016 Jan;136(1):314-317. (PMID: 26763452) Lancet. 2018 Apr 28;391(10131):1706-1717. (PMID: 29650248) Eur Respir J. 2003 Aug;22(2):310-6. (PMID: 12952266) Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):723-32. (PMID: 10934112) Cytokine. 2013 Mar;61(3):772-7. (PMID: 23375121) Cancers (Basel). 2020 Dec 02;12(12):. (PMID: 33276546) Int Wound J. 2020 Feb;17(1):197-205. (PMID: 31691483) J Am Acad Dermatol. 2019 Aug;81(2):510-519. (PMID: 31009665) Allergy. 2023 Apr;78(4):1047-1059. (PMID: 36271804) Respirology. 2017 Jul;22(5):913-921. (PMID: 28139852) Exp Dermatol. 2007 Jan;16(1):28-36. (PMID: 17181634) Biomedicines. 2020 Oct 08;8(10):. (PMID: 33050042) J Immunol. 1996 Dec 15;157(12):5613-26. (PMID: 8955214) Eur Respir J. 2008 Nov;32(5):1243-9. (PMID: 18579545) Front Immunol. 2022 Jul 29;13:930947. (PMID: 35967338) Cancers (Basel). 2022 Oct 17;14(20):. (PMID: 36291863) Inflammopharmacology. 2013 Dec;21(6):397-406. (PMID: 23846739) Can J Neurol Sci. 2017 Jan;44(1):96-104. (PMID: 27832827) J Allergy Clin Immunol. 2018 Jun;141(6):2027-2036.e12. (PMID: 29709671) Nat Rev Rheumatol. 2012 Jan 31;8(3):133-43. (PMID: 22293759) Mol Med Rep. 2016 Aug;14(2):1283-9. (PMID: 27314424) Curr Opin Neurol. 2015 Jun;28(3):193-205. (PMID: 25887774) Horm Metab Res. 2016 Dec;48(12):847-853. (PMID: 27300476) Am J Rhinol Allergy. 2013 Jul-Aug;27(4):266-72. (PMID: 23883806) Acta Dermatovenerol Croat. 2009;17(3):226-34. (PMID: 19818224) Ann Am Thorac Soc. 2020 Jun;17(6):688-698. (PMID: 32079410) Cells. 2022 Sep 05;11(17):. (PMID: 36078171) Front Immunol. 2022 Feb 25;13:812431. (PMID: 35281057) Cell. 2015 Feb 26;160(5):816-827. (PMID: 25723161) FEBS J. 2007 Sep;274(18):4904-12. (PMID: 17824960) J Affect Disord. 2019 Dec 1;259:302-313. (PMID: 31450139) Respir Res. 2019 Mar 4;20(1):49. (PMID: 30832670) Allergy. 2012 Jun;67(6):732-40. (PMID: 22462754) AIDS. 2015 Feb 20;29(4):463-71. (PMID: 25630041) J Allergy Clin Immunol. 2013 Sep;132(3):567-574.e12. (PMID: 23726041) J Eur Acad Dermatol Venereol. 2012 Jul;26(7):812-20. (PMID: 22211801) Pharmacol Rev. 2013 Nov 11;66(1):1-79. (PMID: 24218476) J Allergy Clin Immunol. 2019 Oct;144(4):1011-1024. (PMID: 31356921) J Investig Med. 2015 Mar;63(3):545-7. (PMID: 25654294) J Neuroimmunol. 2009 Apr 30;209(1-2):114-20. (PMID: 19217671) BMC Immunol. 2014 Mar 10;15:12. (PMID: 24612750) Biochem Biophys Res Commun. 1999 Feb 16;255(2):470-6. (PMID: 10049733) Signal Transduct Target Ther. 2021 Jul 12;6(1):263. (PMID: 34248142) Arch Oral Biol. 2014 Jun;59(6):645-53. (PMID: 24751778) Front Immunol. 2021 Jul 19;12:700521. (PMID: 34349761) Immune Netw. 2016 Jun;16(3):189-94. (PMID: 27340388) Obesity (Silver Spring). 2006 May;14(5):799-811. (PMID: 16855189) Clin Infect Dis. 2021 Aug 16;73(4):621-630. (PMID: 33852720) Front Oncol. 2022 Dec 01;12:1034737. (PMID: 36531002) Acta Ophthalmol. 2019 Feb;97(1):e122-e128. (PMID: 30242977) Mod Rheumatol. 2013 Sep;23(5):856-63. (PMID: 23007802) J Psychiatr Res. 2020 Jan;120:29-33. (PMID: 31629996) Arch Physiol Biochem. 2016 Jul;122(3):117-22. (PMID: 26890442) J Pathol. 2001 Jun;194(2):239-46. (PMID: 11400154) Ann Allergy Asthma Immunol. 2021 Sep;127(3):334-341. (PMID: 33975024) Expert Opin Biol Ther. 2014 Feb;14(2):165-81. (PMID: 24283478) IJID Reg. 2022 Mar 10;3:89-95. (PMID: 35755471) Immunopharmacol Immunotoxicol. 2012 Oct;34(5):852-7. (PMID: 22393877) Front Immunol. 2020 Mar 25;11:423. (PMID: 32269565) Clin Dermatol. 2007 Jan-Feb;25(1):9-18. (PMID: 17276196) Adv Ther. 2017 Jul;34(7):1584-1585. (PMID: 28646391) J Leukoc Biol. 1997 Nov;62(5):620-33. (PMID: 9365117) Mediators Inflamm. 2013;2013:691023. (PMID: 23956504) Int J Mol Sci. 2020 Aug 06;21(16):. (PMID: 32781743) Lancet. 2014 Jul 19;384(9939):258-71. (PMID: 24907868) Br J Dermatol. 2010 Feb 1;162(2):332-6. (PMID: 19747218) Eur Cytokine Netw. 2001 Jul-Sep;12(3):468-77. (PMID: 11566628) Genes Immun. 2010 Mar;11(2):142-54. (PMID: 19865101) Biomed Res Int. 2020 May 18;2020:5019793. (PMID: 32509861) Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7265-70. (PMID: 12756299) |
| فهرسة مساهمة: | Keywords: CCL13; MCP-4; NF-κB; Th2; cytokines; human diseases; type 2 immunity |
| المشرفين على المادة: | 0 (Chemokines, CC) 0 (CCL13 protein, human) 0 (Monocyte Chemoattractant Proteins) |
| تواريخ الأحداث: | Date Created: 20230508 Date Completed: 20230509 Latest Revision: 20230509 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC10154514 |
| DOI: | 10.3389/fimmu.2023.1176639 |
| PMID: | 37153575 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder كن أول من يترك تعليقا!